This Day On The Street
Continue to site right-arrow
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
TheStreet Open House

Synageva BioPharma Corp (GEVA)

NASDAQ: Health Care

Company Balance Sheet
Dec 2013 Dec 2012 Dec 2011 Dec 2010
Assets
Cash and Equivalents 62.14M 23.88M 60.23M 45.16M
Receivables 1.37M 2.60M 3.45M 3.67M
Inventories 0.00 0.00 0.00 0.00
Other Current Assets 0.00 3.56M 0.00 0.00
Total Current Assets 416.72M 225.11M 64.65M 49.12M
Property, Plant & Equipment, Gross 23.91M 7.34M 3.65M 0.00
Accumulated Depreciation & Depletion 6.70M 3.33M 2.39M 0.00
Property, Plant & Equipment, Net 17.21M 4.01M 1.26M 0.00
Intangibles 3.49M 5.56M 8.80M 2.20M
Other Non-Current Assets 1.99M 38.00K 59.89K 5.64M
Total Non-Current Assets 31.23M 18.15M 18.65M 8.16M
Liabilities & Shareholder Equity
Total Assets 447.95M 243.26M 83.30M 57.28M
Accounts Payable 2.43M 2.58M 1.51M 0.00
Short Term Debt 0.00 0.00 0.00 0.00
Other Current Liabilities 0.00 587.00K 0.00 0.00
Total Current Liabilities 13.92M 13.08M 8.26M 1.00M
Long Term Debt 0.00 0.00 0.00 0.00
Deferred Income Taxes 0.00 0.00 0.00 0.00
Other Non-Current Liabilities 3.83M 0.00 991.10K 902.00K
Minority Interest 0.00 0.00 0.00 0.00
Total Non-Current Liabilities 3.83M 0.00 991.10K 902.00K
Total Liabilities 17.75M 13.08M 9.25M 1.90M
Preferred Stock Equity 0.00 0.00 0.00 0.00
Common Stock Equity 430.20M 230.18M 74.05M 55.38M
Common Par 31.00K 24.00K 17.58K 22.00K
Additional Paid In Capital 684.47M 388.94M 189.87M 358.58M
Cumulative Translation Adjustment 0.00 0.00 0.00 0.00
Retained Earnings -254.24M -158.79M -115.84M -303.40M
Treasury Stock 0.00 0.00 0.00 0.00
Other Equity Adjustments -59.00K 6.00K -3.53K 174.00K
Total Capitalization 430.20M 230.18M 74.05M 55.38M
Total Equity 430.20M 230.18M 74.05M 55.38M
Total Liabilities & Stock Equity 447.95M 243.26M 83.30M 57.28M
Total Common Shares Outstanding 30.77M 24.47M 17.58M 4.46M
Preferred Shares 0.00 0.00 0.00 0.00
Treasury Shares 0.00 0.00 0.00 0.00
Basic Weighted Shares Outstanding 28.09M 22.58M 2.95M 4.46M
Diluted Weighted Shares Outstanding 28.09M 22.58M 2.95M 4.46M
Number of Employees 172 115 82 3
Number of Part-Time Employees 0 0 0 0
GEVA News

GEVA Synageva BioPharma Corp

Analysts Ratings for GEVA

Rating Current 1-Mo Ago 2-Mo Ago 3-Mo Ago
Strong Buy 5 5 5 5
Moderate Buy 0 0 0 1
Hold 1 1 1 1
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
GET GEVA ANALYST REPORT

Brokerage Partners

GEVA Chatter

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
Real Money Pro

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Trifecta Stocks

Trifecta Stocks analyzes over 4,000 equities weekly to find the elite 1% of stocks that pass rigorous quantitative, fundamental and technical tests.

Product Features:
  • Model portfolio
  • Trade alerts
  • Recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
Stocks Under $10

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Dividend Stock Advisor

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Breakout Stocks

Bryan Ashenberg, using sophisticated stock screening and fundamental research, identifies potentially explosive small and mid-cap stocks.

Product Features:
  • Model portfolio
  • Small-cap and mid-cap focus
  • Intraday trade alerts
  • Weekly roundups
Options Profits

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
Top Rated Stocks Top Rated Funds Top Rated ETFs